1. Home
  2. ATNM vs UONEK Comparison

ATNM vs UONEK Comparison

Compare ATNM & UONEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

HOLD

Current Price

$0.98

Market Cap

31.7M

Sector

Health Care

ML Signal

HOLD

Logo Urban One Inc. Class D

UONEK

Urban One Inc. Class D

HOLD

Current Price

$4.84

Market Cap

26.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATNM
UONEK
Founded
2000
1980
Country
United States
United States
Employees
N/A
1272
Industry
Biotechnology: Pharmaceutical Preparations
Broadcasting
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
31.7M
26.8M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
ATNM
UONEK
Price
$0.98
$4.84
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$4.50
N/A
AVG Volume (30 Days)
136.3K
4.3K
Earning Date
05-06-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
14.17
N/A
EPS
N/A
N/A
Revenue
$90,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
11.11
N/A
52 Week Low
$0.94
$0.45
52 Week High
$1.89
$9.38

Technical Indicators

Market Signals
Indicator
ATNM
UONEK
Relative Strength Index (RSI) 39.02 52.40
Support Level $0.97 $4.75
Resistance Level $1.11 $5.32
Average True Range (ATR) 0.05 0.34
MACD 0.00 0.05
Stochastic Oscillator 24.12 67.17

Price Performance

Historical Comparison
ATNM
UONEK

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of targeted radiotherapies using its Antibody Radiation Conjugates (ARCs) platform, which combines monoclonal antibodies with radioisotopes to selectively target and destroy cancer cells. The company's product candidates include Iomab-B, an iodine-131 based radiotherapy for conditioning prior to hematopoietic stem cell transplantation, and Actimab-A, an actinium-225 based radiotherapy in clinical development for acute myeloid leukemia. The company is also advancing additional programs, including Iomab-ACT for cell and gene therapy conditioning and other preclinical candidates targeting solid tumors.

About UONEK Urban One Inc. Class D

Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.

Share on Social Networks: